- 501. Alphabetic
- [Alphabetic transcription of name (Japanese: romaji) ( HL7V3.0 )] (UMLS (HL7) C1553380) =Idea or Concept =NameRepresentationUse;
| - 551. Althose
- (UMLS (NCI) C0699059) =Organic Chemical; Pharmacologic Substance
|
- 502. Alphabetic (i.e., Default or some single-byte)
- (UMLS (HL7) C1547500) =Idea or Concept =Name/address representation;
| - 552. altitude
- [height above sea level or above the earth's surface. ( CSP )] (UMLS (CSP) C0002349) =Quantitative Concept
|
- 503. Alphaherpesvirinae
- [a subfamily of Herpesviridae; replicate rapidly and latent infection is often demonstrable in nerve ganglia. ( CSP )] (UMLS (CSP) C0206557) =Virus =herpes virus;
=herpes simplex virus 2;
B virus;
chickenpox virus;
herpes simplex virus 1;
suid alphaherpesvirus 1 | - 553. altitude sickness
- [A morbid condition of ANOXIA caused by the reduced available oxygen at high altitudes. ( MSH )] (UMLS (CSP) C0002351) =Disease or Syndrome
|
- 504. Alphanumeric
- [A term used to describe a character string containing only letters and numbers. ( NCI )] (UMLS (NCI) C0439063) =Intellectual Product
| - 554. Altretamine/Carboplatin/Cyclophosphamide
- (UMLS (NCI) C0280871) =Therapeutic or Preventive Procedure ;
|
- 505. AlphaPAK
- [p21-Activated Kinase 1, encoded by the PAK1 gene, shares a high degree of sequence similarity with p21-activated kinase (PAK) family members. PAK proteins, a family of serine/threonine p21-activating kinases, include PAK1, PAK2, PAK3 and PAK4. These proteins are critical effectors that link RhoGTPases to cytoskeleton reorganization and nuclear signaling and serve as targets for the small GTP binding proteins Cdc42 and Rac and have been implicated in a wide range of biological activities. PAK1 regulates cell motility and morphology. Alternative transcripts of this gene have been found, but their full-length natures have not yet been determined. (from Gene) ( NCI )] (UMLS (NCI) C0299856) =Amino Acid, Peptide, or Protein; Enzyme
| - 555. Altretamine/Carboplatin/Cyclophosphamide/Doxorubicin
- (UMLS (NCI) C0279977) =Therapeutic or Preventive Procedure
|
- 506. alpharetrovirus
- [genus of the family retroviridae with type C morphology that causes malignant and other diseases in wild birds and domestic fowl; widespread vertically and horizontally transmitted exogenous and endogenous viruses; associated with malignancies, wasting, and osteopetrosis. ( CSP )] (UMLS (CSP) C0004423) =Virus ;
| - 556. Altretamine/Carmustine/Mitomycin
- (UMLS (NCI) C0279189) =Therapeutic or Preventive Procedure
|
- 507. Alphavirus
- [genus of Togaviridae, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae; viruses are transmitted by mosquitoes. ( CSP )] (UMLS (CSP) C0002331) =Virus
| - 557. Altretamine/Cisplatin
- (UMLS (NCI) C0279483) =Therapeutic or Preventive Procedure
|
- 508. Alphax Integrin Chain
- [Part of the integrin CR4, aka Complement Receptor 4, the CD11c/CD18 heterodimer. (Fundamental Immunology, 3rd ed., William Paul, ed., Raven Press, NY 1993, pg 927) ( NCI )] (UMLS (NCI) C0023395) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 558. Altretamine/Cisplatin/Cyclophosphamide
- (UMLS (NCI) C0280604) =Therapeutic or Preventive Procedure
|
- 509. Alport syndrome
- [hereditary disorder characterized by progressive sensorineural hearing loss, progressive pyelonephritis or glomerulonephritis, and, occasionally, ocular defects; transmitted as an autosomal dominant or X-linked trait. ( CSP )] (UMLS (CSP) C1567741) Alport's Syndrome;
=Disease or Syndrome; ;
=Hearing Loss, Sensorineural;
Genetic Condition;
nephritis;
syndrome | - 559. Altretamine/Cisplatin/Cyclophosphamide/Doxorubicin
- (UMLS (NCI) C0056451) =Therapeutic or Preventive Procedure
|
- 510. alprazolam
- [8-chloro-1-methyl-6-phenyl-s-triazolo benzodiazepine, has both antidepressant and anxiolytic properties; possible efficacy in alcohol withdrawal therapy; abuse can lead to habituation or addiction. ( CSP )] (UMLS (CSP) C0002333) =Organic Chemical; Pharmacologic Substance ;
| - 560. Altretamine/Cisplatin/Cyclophosphamide/Fluorouracil
- (UMLS (NCI) C0279427) =Therapeutic or Preventive Procedure
|
- 511. alprenolol
- [One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent. ( MSH )] (UMLS (CSP) C0002334) =Organic Chemical; Pharmacologic Substance ;
| - 561. Altretamine/Cisplatin/Cyclophosphamide/Misonidazole
- (UMLS (NCI) C0279336) =Therapeutic or Preventive Procedure
|
- 512. ALPS
- (UMLS (NCI) C1328840) ALPS (autoimmune lymphoproliferative syndrome);
Autoimmune Lymphoproliferative Syndrome;
Canale-Smith Syndrome =Disease or Syndrome ;
| - 562. Altretamine/Cisplatin/Doxorubicin
- (UMLS (NCI) C0062074) =Therapeutic or Preventive Procedure ;
|
- 513. ALPS2
- [Caspase-10, encoded by the CASP10 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Caspases exist as inactive proenzymes that undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspase-10 is involved in the activation cascade of caspases responsible for apoptosis execution. It is recruited to both FAS- and TNFR-1 receptors in a FADD dependent manner. Caspase-10 cleaves and activates Caspases-3, -4, -6, -7, -8, and -9, and itself can be processed by Caspase-8. Mutations in the CASP10 gene are associated with apoptosis defects seen in type II autoimmune lymphoproliferative syndrome. Four alternatively spliced transcript variants encoding different isoforms have been described for this gene. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0758959) Apoptotic Protease MCH-4;
CASP10;
CASP10 Protein;
Caspase 10, Apoptosis-Related;
Caspase 10, Apoptosis-Related Cysteine Protease;
Caspase-10;
Cysteine Protease;
EC 3.4.22.-;
FADD-Like ICE2;
Fas-Associated Death Domain Protein;
FAS-Associated Death Domain Protein Interleukin-1B-Converting Enzyme 2;
FLICE2;
ICE-Like Apoptotic Protease 4;
Interleukin-1B-Converting Enzyme 2;
MCH4 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 563. Altretamine/Cisplatin/Etoposide
- (UMLS (NCI) C0281013) =Therapeutic or Preventive Procedure
|
- 514. ALRT1057
- (UMLS (NCI) C0918022) =Organic Chemical; Pharmacologic Substance ;
| - 564. Altretamine/Cisplatin/Etoposide/Mitomycin
- (UMLS (NCI) C0065958) =Therapeutic or Preventive Procedure
|
- 515. ALS
- [progressive degeneration of the neurons that give rise to the corticospinal tract and of the motor cells of the brain stem and spinal cord, resulting in a deficit of upper and lower motor neurons. ( CSP )] (UMLS (CSP) C0002736) =Disease or Syndrome
| - 565. Altretamine/Cyclophosphamide/Doxorubicin
- (UMLS (NCI) C0279470) =Therapeutic or Preventive Procedure
|
- 516. AlS2Pc
- [An amphiphilic compound that exhibits a direct phototoxic effect, thereby inducing tumor necrosis. (NCI) ( NCI )] (UMLS (NCI) C0081549) =Organic Chemical; Pharmacologic Substance
| - 566. Altretamine/Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen/Vinblastine
- (UMLS (NCI) C0280615) =Therapeutic or Preventive Procedure
|
- 517. Alsatian
- [The German Shepherd Dog is also known as the Alsatian. It is well proportioned and very strong. The coat most often comes in black with tan, sable or all black. It has a sturdy, muscular, slightly elongated body with a light but solid bone structure. It has round feet with very hard soles. Height: 22-26 inches (55-65 cm.) Weight: 77-85 pounds (35-40 kg.) ( NCI )] (UMLS (NCI) C0324373) =Mammal
| - 567. Altretamine/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine
- (UMLS (NCI) C0279335) =Therapeutic or Preventive Procedure
|
- 518. AlSPc
- [A rhodamine-based dye used as a photosensitizing agent in cytotoxic photodynamic therapy. (NCI) ( NCI )] (UMLS (NCI) C0055390) =Organic Chemical; Pharmacologic Substance ;
| - 568. Altretamine/Cyclophosphamide/Doxorubicin/Vincristine
- (UMLS (NCI) C0279183) =Therapeutic or Preventive Procedure
|
- 519. alstonia
- [A plant genus of the family APOCYNACEAE. Members contain echitovenidine, echitamine, venenatine (an indole alkaloid), and anti-inflammatory triterpenoids ( MSH )] (UMLS (CSP) C0599279) =Plant
| - 569. Altretamine/Cyclophosphamide/Fluorouracil/Methotrexate
- (UMLS (NCI) C0062594) =Therapeutic or Preventive Procedure
|
- 520. Alstrom syndrome
- [ ] (UMLS (CSP) C0268425) =Congenital Abnormality; Disease or Syndrome
| - 570. Altretamine/Cyclophosphamide/Methotrexate
- (UMLS (NCI) C0279409) =Therapeutic or Preventive Procedure
|
- 521. ALT
- [Activity measured as a test of liver function, human Glutamic-Pyruvate Transaminases (Alanine Aminotransferase Family) are pyridoxal phosphate-dependent enzymes involved in cellular nitrogen metabolism, amino acid metabolism, and liver gluconeogenesis. Glutamic Pyruvic Transaminases mediate conversion of major intermediate metabolites, catalyzing reversible transamination between alanine and alpha-ketoglutarate to form pyruvate and glutamate. (NCI) ( NCI )] (UMLS (NCI) C0376147) =Amino Acid, Peptide, or Protein; Enzyme
| - 571. Altretamine/Doxorubicin/Fluorouracil/Mitomycin
- (UMLS (NCI) C0279486) =Therapeutic or Preventive Procedure
|
- 522. ALT ESOTROP W X/Y PATTRN
- [ ] (UMLS (ICD9CM) C0155327) =Disease or Syndrome
| - 572. Altretamine/Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Prednisone/Tamoxifen/Vincristine
- (UMLS (NCI) C0280614) =Therapeutic or Preventive Procedure
|
- 523. ALT ESOTROPIA W A PATTRN
- [ ] (UMLS (ICD9CM) C0155325) =Disease or Syndrome
| - 573. Altretamine/Doxorubicin/Melphalan
- (UMLS (NCI) C0279477) =Therapeutic or Preventive Procedure
|
- 524. ALT ESOTROPIA W V PATTRN
- [ ] (UMLS (ICD9CM) C0155326) =Disease or Syndrome
| - 574. Altretamine/Doxorubicin/Methotrexate
- (UMLS (NCI) C0279479) =Therapeutic or Preventive Procedure
|
- 525. ALT EXOTROP W X/Y PATTRN
- [ ] (UMLS (ICD9CM) C0155333) =Disease or Syndrome
| - 575. Altretamine/Etoposide
- (UMLS (NCI) C0281629) =Therapeutic or Preventive Procedure
|
- 526. ALT EXOTROPIA W A PATTRN
- [ ] (UMLS (ICD9CM) C0155331) =Disease or Syndrome
| - 576. Altretamine/Etoposide/Methotrexate
- (UMLS (NCI) C0280599) =Therapeutic or Preventive Procedure
|
- 527. ALT EXOTROPIA W V PATTRN
- [ ] (UMLS (ICD9CM) C0155332) =Disease or Syndrome
| - 577. Altretamine/Etoposide/Procarbazine
- (UMLS (NCI) C0279464) =Therapeutic or Preventive Procedure
|
- 528. Altace
- (UMLS (NCI) C0878061) =Organic Chemical; Pharmacologic Substance
| - 578. Altretamine/Lomustine/Methotrexate
- (UMLS (NCI) C0279430) =Therapeutic or Preventive Procedure
|
- 529. Alteration In Cognition
- [Pertaining to or characterized by cognition. That operation of the mind which we become aware of objects of thought or perception; it includes all aspects of perceiving, thinking, or remembering. ( NCI )] (UMLS (NCI) C1392786) Alteration Of Cognitive Function;
Changes, cognitive;
Cognitive Alteration;
Cognitive Change;
Cognitive Changes =Mental or Behavioral Dysfunction ;
| - 579. Altretamine/Mitomycin/Vinblastine
- (UMLS (NCI) C0291012) =Therapeutic or Preventive Procedure
|
- 530. Alteration in Respiration
- (UMLS (NCI) C0184551) =Finding ;
| - 580. Altretamine/Paclitaxel
- (UMLS (NCI) C0281302) =Therapeutic or Preventive Procedure ;
|
- 531. Alteration of consciousness
- [ ] (UMLS (ICD9CM) C0234428) =Sign or Symptom
| - 581. altruism
- [consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence. ( CSP )] (UMLS (CSP) C0002357) =Social Behavior
|
- 532. ALTERATION OF SENSATIONS
- (UMLS (ICD9CM) C1135206) Alterations of sensations =Disease or Syndrome
| - 582. Alturas Indian Rancheria, California
- (UMLS (HL7) C1554224) =Population Group =NativeEntityContiguous;
|
- 533. Alterations in Hearing
- (UMLS (NCI) C0429199) =Finding
| - 583. Alum adjuvant/gp100 antigen/Interleukin-12/MART-1 antigen/Montanide ISA-51/tyrosinase peptide
- (UMLS (NCI) C1134584) =Therapeutic or Preventive Procedure ;
|
- 534. Alterations in Smell or Taste
- (UMLS (NCI) C1332239) =Sign or Symptom ;
| - 584. Alum Adjuvant/Monoclonal Antibody 105AD7 Anti-Idiotype Vaccine
- (UMLS (NCI) C1134502) =Therapeutic or Preventive Procedure
|
- 535. ALTERED MENTAL STATUS
- (UMLS (ICD9CM) C0278061) =Mental or Behavioral Dysfunction
| - 585. Alum adjuvant/Monoclonal antibody 4B5 anti-idiotype vaccine
- (UMLS (NCI) C0879387) =Therapeutic or Preventive Procedure
|
- 536. Alternaria
- [A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia. ( MSH )] (UMLS (CSP) C0002343) =Fungus
| - 586. ALUMINUM ACETATE
- [A topical astringent that is used as an antiseptic agent. Aluminum acetate is used to treat inflammation, itching, and stinging of the infected skin and promotes healing. ( NCI )] (UMLS (NCI) C0051510) =Organic Chemical; Pharmacologic Substance ;
=acetate;
Inactive Ingredient Preparations =ALUMINUM ACETATE SOLN;
ALUMINUM ACETATE POWDER (GM);
ALUMINUM ACETATE/BENZETHONIUM CL PWDR,TOP;
ALUMINUM ACETATE/ZINC OXIDE PASTE,TOP;
ALUMINUM ACETATE 325 MG;
CARMEX OINT,TOP;
ALUMINUM ACETATE 10.79 %;
ALUMINUM ACETATE 10 %;
|
- 537. alternate
- [Designates substitute versions for the document in which the link occurs. When used together with the lang attribute, it implies a translated version of the document. When used together with the media attribute, it implies a version designed for a different medium (or media). ( HL7V3.0 )] (UMLS (HL7) C1552848) =Idea or Concept =HtmlLinkType;
| - 587. aluminum oxide
- [compound, occurring naturally as corundum and in hydrated form as bauxite, that is the raw material in aluminum production. ( CSP )] (UMLS (CSP) C0002374) =Biomedical or Dental Material; Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical
|
- 538. Alternate character set handling scheme
- (UMLS (HL7) C1547750) =Idea or Concept =HL7 Vocabulary Version 2.5;
=This is the default, indicating that there is no character set switching occurring in this message.;
"The character set switching mode specified in HL7 2.5, section 2.7.2, _Escape sequences supporting multiple character sets_ and section 2.A.46, ""XPN _ extended person name""."
;"This standard is titled ""Information Technology - Character Code Structure and Extension Technique"". ." | - 588. Aluminum Stearate
- [The aluminum salt of the fatty acid, stearic acid. ( NCI )] (UMLS (NCI) C0102850) =Lipid; Biomedical or Dental Material
|
- 539. Alternate character sets
- (UMLS (HL7) C1547621) =Intellectual Product =HL7 Vocabulary Version 2.5;
=The printable characters from the ISO 8859/1 Character set;
The printable characters from the ISO 8859/2 Character set;
The printable characters from the ISO 8859/3 Character set;
The printable characters from the ISO 8859/4 Character set;
The printable characters from the ISO 8859/5 Character set;
The printable characters from the ISO 8859/6 Character set;
The printable characters from the ISO 8859/7 Character set;
The printable characters from the ISO 8859/8 Character set;
The printable characters from the ISO 8859/9 Character set;
The printable 7-bit ASCII character set.;
Code for Taiwanese Character Set (BIG-5);
Code for Taiwanese Character Set (CNS 11643-1992);
Code for Chinese Character Set (GB 18030-2000);
Code for Information Exchange (one byte)(JIS X 0201-1976).;
Code of the supplementary Japanese Graphic Character set for information interchange (JIS X 0212-1990).;
Code for the Japanese Graphic Character set for information interchange (JIS X 0208-1990),;
Code for Korean Character Set (KS X 1001);
The world wide character standard from ISO/IEC 10646-1-1993;
UCS Transformation Format, 16-bit form;
UCS Transformation Format, 32-bit form;
UCS Transformation Format, 8-bit form | - 589. Alupent
- (UMLS (NCI) C0591074) =Organic Chemical; Pharmacologic Substance
|
- 540. alternate electronic
- [Payment initiated by the payor as the result of adjudicating a submitted invoice that arrived to the payor from an electronic source that did not provide a conformant set of HL7 messages (e.g. web claim submission). ( HL7V3.0 )] (UMLS (HL7) C1555704) =Intellectual Product =ActInvoiceAdjudicationPaymentGroupCode;
| - 590. Alutiiq
- (UMLS (HL7) C1556071) =Language =SirenikskiYupik;
|
- 541. Alternate Splicing
- [Alternate Splicing is a process in which multiple protein isoforms or products are generated from a single gene as a result of splicing together different nonconsecutive exons during the processing of initially identical nascent transcripts of a gene into mature mRNA transcripts. An exon may be connected to any one of several alternative exons to form the mRNA and generate related proteins, often in a tissue or developmental stage specific manner. ( NCI )] (UMLS (NCI) C0002345) =Genetic Function
| - 591. ALV
- [species in the genus Alpharetrovirus, producing latent or manifest lymphoid leukosis in fowl. ( CSP )] (UMLS (CSP) C0004422) =Virus ;
|
- 542. ALTERNATING ESOTROPIA
- (UMLS (ICD9CM) C0152205) =Disease or Syndrome ;
| - 592. ALVAC
- [A vaccine based upon the ALVAC Canarypox virus vector. ( NCI )] (UMLS (NCI) C0211671) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Immunologic Factor
|
- 543. ALTERNATING EXOTROPIA
- [ ] (UMLS (ICD9CM) C0152207) =Disease or Syndrome ;
| - 593. ALVAC CEA B7.1 Vaccine
- [A cancer vaccine that uses a viral vector system derived from the canarypox virus engineered to target the carcinoembryonic antigen (CEA). It causes infected cells to temporarily display CEA and activates the immune system to attack the tumor cells. ( NCI )] (UMLS (NCI) C1134540) ALVAC-CEA B7.1 Vaccine =Pharmacologic Substance; Immunologic Factor ;
|
- 544. ALTERNATING HYPERPHORIA
- [ ] (UMLS (ICD9CM) C0152220) =Disease or Syndrome ;
| - 594. ALVAC hB7.1/IFN-G
- (UMLS (NCI) C0677795) =Therapeutic or Preventive Procedure
|
- 545. alternative complement pathway
- [complement activation sequence initiated by the activation of complement factor C3, which is triggered by the interaction of microbial polysaccharides and properdin without participation of an antigen-antibody reaction. ( CSP )] (UMLS (CSP) C0009546) =Molecular Function ;
=Complement Pathway;
| - 595. ALVAC-CEA
- [A cancer vaccine containing a canary pox virus (ALVAC) combined with the human carcinoembryonic antigen (CEA) gene. ( NCI )] (UMLS (NCI) C0338246) =Pharmacologic Substance; Biologically Active Substance ;
|
- 546. Alternative explanations for the event available
- (UMLS (HL7) C1546997) =Idea or Concept =Causality Observations;
| - 596. ALVAC-CEA Vaccine/Sargramostim
- (UMLS (NCI) C0677999) =Therapeutic or Preventive Procedure
|
- 547. Alternative Level of Care
- [Provision of Alternate Level of Care to a patient in an acute bed. Patient is waiting for placement in a long-term care facility and is unable to return home. ( HL7V3.0 )] (UMLS (HL7) C1555460) =Intellectual Product =ActMedicalServiceCode;
| - 597. ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium
- (UMLS (NCI) C1134541) =Therapeutic or Preventive Procedure
|
- 548. Alternative Macrophage Activation-Associated CC Chemokine 1
- [Induced by glucocorticoids, PMA, IL-4, IL-13, and IL-10 and expressed by human CCL18 Gene (Intercrine Beta Family) in lung, lymph nodes, placenta, bone marrow, dendritic cells, and macrophages, secreted 89-aa 10-kDa (precursor) Small Inducible Cytokine A18, an immunoregulatory chemotactic cytokine for naive T cells, CD4+ and CD8+ T cells, and nonactivated lymphocytes involved in inflammatory processes s well as humoral and cell-mediated immunity. CCL18 may be involved in B cell migration into lymph node follicles. (NCI) ( NCI )] (UMLS (NCI) C0541270) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 598. ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium/Tetanus toxoid
- (UMLS (NCI) C1134542) =Therapeutic or Preventive Procedure
|
- 549. alternative medicine
- [diagnostic or therapeutic technique which is presently outside the field of conventional medical practice; for use as a 'tag' term index at 'T' emphasis level. ( CSP )] (UMLS (CSP) C0002346) =Biomedical Occupation or Discipline
| - 599. ALVAC-CEA-B7.1 Vaccine/Tetanus Toxoid
- (UMLS (NCI) C1327928) =Therapeutic or Preventive Procedure; ;
|
- 550. alternatives to animals in research
- [methods which refine, reduce, or replace the use of animals in research; includes those projects which replace one animal species with a phylogenetically lower species. ( CSP )] (UMLS (CSP) C0003059) =Research Activity ;
| - 600. ALVAC-hB7.1
- [A vaccine comprise of a canarypox viral vector that carries the gene for human B7.1 (CD80 antigen) with potential use as an autologous therapeutic cancer vaccine. Tumor cells harvested from a patient are infected with ALVAC-hB7 1, thereby producing an autologous cell line that exhibits increased expression of HLA class I and class II, CD54 (ICAM), and CD80. Increased expression of these proteins by this autologous cell line may activate an antitumor T-cell response when the modified cells are administered to the patient. (NCI04) ( NCI )] (UMLS (NCI) C0796294) =Pharmacologic Substance; Immunologic Factor
|
home
